A Study of LY3041658 in Adults With Hidradenitis Suppurativa

ID# NCT04493502

Recruitment Status: Recruiting

Estimated Study Completion Date: July 4, 2022

HS Connect listed this: October 2020

Sponsor: Eli Lilly and Company

Information provided by (Responsible Party):Eli Lilly and Company


Brief Summary:

The reason for this study is to see if the study drug LY3041658 is effective in participants with moderate-to-severe hidradenitis suppurativa (HS).


Please link for complete trial details:



Location: Multiple US locations. Please see link above for all location details and to confirm your location is recruiting.


Contact Information: 


Contact: 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559

Email: ClinicalTrials.gov@lilly.com


© 2021 by HS Connect, LLC  |  HSConnect.org@gmail.com  |  PO Box 73244 Puyallup, WA 98373  |  253.256.1579